Get the Stockscreener App
0.7049
1.10%
0.0077
Pre-market:
.69
-0.0149
-2.11%
Envveno Medical Corporation stock is traded at $0.7049, with a volume of 748.63K.
It is up +1.10% in the last 24 hours and down -22.21% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$0.6972
Open:
$0.6484
24h Volume:
748.63K
Relative Volume:
0.78
Market Cap:
$13.57M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-0.3279
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
-0.97%
1M Performance:
-22.21%
6M Performance:
-76.50%
1Y Performance:
-79.08%
1-Day Range:
$0.6198
$0.71
1-Week Range:
$0.6198
$0.75
52-Week Range:
$0.6198
$5.62
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
0.7049 | 13.42M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Envveno Medical Corporation Stock (NVNO) Latest News
What Wall Street predicts for enVVeno Medical Corporation stock priceTrade Risk Assessment & Free High Return Stock Watch Alerts - newser.com
Visualizing enVVeno Medical Corporation stock with heatmaps2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
Published on: 2025-11-03 02:36:48 - newser.com
enVVeno Medical Corporation stock prediction for this weekGlobal Markets & Risk Adjusted Swing Trade Ideas - newser.com
enVVeno Medical Corporation stock trend forecast2025 Bull vs Bear & Daily Market Momentum Tracking - newser.com
Price momentum metrics for enVVeno Medical Corporation explained2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com
How to use a screener to detect enVVeno Medical Corporation breakoutsWeekly Profit Report & Daily Growth Stock Investment Tips - newser.com
Can enVVeno Medical Corporation stock sustain market leadershipWeekly Trade Summary & Growth Oriented Trading Recommendations - newser.com
Will enVVeno Medical Corporation (5HJ) stock benefit from Fed rate cuts2025 Key Lessons & AI Driven Stock Price Forecasts - newser.com
Can enVVeno Medical Corporation stock maintain growth trajectoryDividend Hike & Risk Controlled Daily Trade Plans - newser.com
Quantitative breakdown of enVVeno Medical Corporation recent move2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
enVVeno Medical Launches $50M Equity Offering Program - The Globe and Mail
enVVeno Medical reports Q3 EPS (23c) vs. (35c) last year - MSN
NVNO: Financial Stability as FDA Discussions Progress - GuruFocus
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - ACCESS Newswire
enVVeno Medical (NASDAQ: NVNO) funds operations through Q2 2027; cash $31.0M - Stock Titan
Can enVVeno Medical Corporation stock deliver strong Q4 earnings2025 Short Interest & Target Return Focused Stock Picks - newser.com
Will enVVeno Medical Corporation (5HJ) stock justify high valuationWeekly Loss Report & AI Based Buy/Sell Signal Reports - newser.com
Tools to monitor enVVeno Medical Corporation recovery probabilityStop Loss & Daily Stock Momentum Reports - newser.com
Comparing enVVeno Medical Corporation in custom built stock radarsJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
enVVeno Medical sets up at-the-market offering up to $50M - Stock Titan
NVNO launches $50M at-the-market stock program with Ladenburg - Stock Titan
What drives enVVeno Medical Corporation 5HJ stock priceMonthly Performance Summary & Superior Trading Ideas - earlytimes.in
NVNO proxy: director elections, say-on-pay, auditor, 2025 equity plan - Stock Titan
NVNO Q3: FDA not‑approvable letter, Nasdaq bid‑price notice - Stock Titan
Is enVVeno Medical Corporation 5HJ a good long term investmentVolume Spike Alerts & Budget Friendly Portfolio - earlytimes.in
Cash per share of enVVeno Medical Corporation – FWB:5HJ - TradingView
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
14.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):